ATAI: Atai Life Sciences N.V. Stock

by  •  • Comments Off on ATAI: Atai Life Sciences N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 264.50
Enterprise Value ($M) 266.00
Book Value ($M) 223.26
Book Value / Share 1.33
Price / Book 1.18
NCAV ($M) 85.54
NCAV / Share 0.51
Price / NCAV 3.09

Profitability (mra)
Return on Invested Capital (ROIC) -0.14
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.16

Liquidity (mrq)
Quick Ratio 7.72
Current Ratio 7.72

Balance Sheet (mrq) ($M)
Current Assets 131.40
Assets 269.12
Liabilities 45.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.31
Operating Income -125.47
Net Income -40.22

Cash Flow Statement (mra) ($M)
Cash From Operations -84.12
Cash from Investing -53.30
Cash from Financing -8.36

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Apeiron Investment Group Ltd. 20.10 3.72

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 123,137 401,949 30.63
2024-07-25 164,984 439,474 37.54
2024-07-24 77,311 338,372 22.85
2024-07-23 164,034 446,896 36.71
2024-07-22 104,824 298,790 35.08

(click for more detail)

Similar Companies
AQST – Aquestive Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc. ATXS – Astria Therapeutics, Inc.
AUPH – Aurinia Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io